- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02426008
Improving Embryogenesis by Adding Growth Factors to In Vitro Human Culture Media (GFSSSCM)
September 29, 2018 updated by: Muhammad Fawzy, Ibn Sina Hospital
Growth Factors Supplementation to Single-Step Culture Medium
The investigators suppose that adding growth factors that had been found in the female tubal fluid and uterus to In Vitro single step culture media for human embryos might improve the the embryogenesis In Vitro and the clinical outcome of the resulting off spring.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The IVF culture media design and upgrade underwent many ideas during the last 3 decades, we suppose that adding growth factors ( Insulin-like growth factor I, Insulin-like growth factor II, transforming growth factor-beta and epidermal growth factor ) as a promoting growth factors to Lifeglobal culture media might improve embryo development in vitro so we decide to design a trial to compare the embryogenesis by sibling Oocytes of the same patient between to arm of the same culture media and the same culture condition but with one arm with growth factors and the other is traditional one and closely monitor the outcome within the 2 arms and record the results.
Study Type
Interventional
Enrollment (Actual)
426
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Sohag, Egypt
- IbnSina IVF Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- all patients
Exclusion Criteria:
- over 40 years old
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Culture media with growth factors and Cytokine
Growth factors and Cytokine adding to culture media to detect the deference and monitor the embryological outcome.
|
|
|
Placebo Comparator: In Vitro culture media
culture media to monitor the embryological outcome as control group
|
Nothing to Add
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Clinical Pregnancy rate ( % )
Time Frame: 3 months
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
ongoing Pregnancy rate ( % )
Time Frame: 6 months
|
6 months
|
|
rates of blastocyst formation and quality
Time Frame: 6 days of culture
|
6 days of culture
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2015
Primary Completion (Actual)
March 1, 2016
Study Completion (Actual)
March 1, 2016
Study Registration Dates
First Submitted
April 17, 2015
First Submitted That Met QC Criteria
April 21, 2015
First Posted (Estimate)
April 24, 2015
Study Record Updates
Last Update Posted (Actual)
October 2, 2018
Last Update Submitted That Met QC Criteria
September 29, 2018
Last Verified
September 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IbnSina IVF
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on In Vitro Human Embryo Development
-
ShangHai Ji Ai Genetics & IVF InstituteThe University of Hong KongCompletedEmbryo Transfer | Fertilization in VitroChina
-
Centre Hospitalier Universitaire de NīmesRecruitingFertilization in Vitro | Single Embryo TransferFrance, Réunion
-
National Taiwan University HospitalNot yet recruitingEmbryo Transfer | In Vitro Fertilization (IVF)
-
Wuhan UniversityNetherlands: Ministry of Health, Welfare and SportsUnknownIn Vitro Fertilization and Embryo TransferChina
-
Sheba Medical CenterRecruitingEmbryo Transfer | Fertilization in Vitro | CoitusIsrael
-
Jinan Central HospitalUnknownIn Vitro Fertilization | Frozen Embryo TransferChina
-
Toronto Centre for Advanced Reproductive TechnologyUnknownIn Vitro Fertilization | Embryo Transfer | Drug Effects
-
Hoang Minh Ngan16A Ha Dong General HospitalRecruitingInfertility; In Vitro Fertilization; Embryo DevelopmentVietnam
-
Chinese University of Hong KongNot yet recruitingIn Vitro Fertilization (IVF) | Assisted Reproductive Techniques | Cryopreservation of Embryos | Frozen Embryo Transfer (FET) | Pregnancy Outcome After in Vitro Fertilization (IVF)Hong Kong, United Kingdom
-
GinefivTheramexNot yet recruitingBlastocyst | Oocyte Retrieval | Fertilization in Vitro | Embryo | Oocyte | PGT-A | Stimulation in the Ovary
Clinical Trials on Growth Factors and Cytokine adding to embryo culture media
-
Ibn Sina HospitalBanon IVF Center Assiut, EgyptCompleted
-
ART Fertility Clinics LLCRecruiting
-
Ibn Sina HospitalBanon IVF Center Assiut, EgyptCompleted
-
ART Fertility Clinics LLCUniversity Women's Hospital TübingenCompletedInfertility | Aneuploidy | Infertility, FemaleUnited Arab Emirates
-
Newlife Fertility CentreRecruitingInfertility | Infertility,Female | Infertility Unexplained | Infertility of Uterine Origin | Infertility; Female, NonimplantationCanada
-
Hillel Yaffe Medical CenterCompletedObstetric Labor, PrematureIsrael
-
Valme University HospitalUniversity of SevilleUnknown
-
Sohag UniversityNot yet recruiting
-
Wyeth is now a wholly owned subsidiary of PfizerTerminatedRenal Cell CarcinomaUnited States